Navigation Links
Abraxis Provides Overview Of ABRAXANE Study
Date:1/8/2010

astatic disease or relapse within six months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. The U.S. Food and Drug Administration granted orphan-drug designation for ABRAXANE for the treatment of pancreatic cancer in September 2009 and stage IIb to IV melanoma in October 2009. For the full prescribing information for ABRAXANE please visit www.abraxane.com.

About Abraxis BioScience, Inc.
Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE®), which is based on the company's proprietary tumor targeting technology known as the nab®platform. The first FDA approved product to use this nab®platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer and is now approved in 38 countries. The company continues to expand the nab®platform through a robust clinical program and deep product pipeline. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit www.abraxisbio.com.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3416684.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Insight Accelerator Labs has partnered ... development of an in-line urine flow meter platform ... developed in direct response to current high cost ... error margins with potentially grave consequences. The company’s ... provide trending data analysis to signal ICU caregivers ...
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
(Date:2/27/2015)... Muscular Dystrophy Association research grantee Charles ... University, recently announced a potentially game-changing advance in ... Duchenne muscular dystrophy (DMD). The results were published ... discuss their implications at MDA's 2015 Scientific Conference, ... , Background: Gersbach and team are investigating ...
(Date:2/27/2015)... With cases of head lice on ... to school administrations to help prevent the spread of head ... a common parasite that passes easily among children and teens, ... teachers significant distress. , The answer may be found ... This would allow parents and teachers to immediately discover who ...
(Date:2/27/2015)... 2015 BaliniSports is expanding its presence ... fitness social platform FITMOO. The collaboration is aimed to ... philosophy behind BaliniSports. Users of FITMOO will be able ... and discover apparel that will enhance their workouts. , ... friendly and socially conscious methods to produce its line ...
Breaking Medicine News(10 mins):Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:South Florida Parents Put Pressure on Schools to Perform Lice Screenings to Prevent Spread of Lice According to One Miami Lice Removal Company Called Lice Troopers 2Health News:BaliniSports Announces Collaboration with FITMOO 2
... September 28, 2011 - (BRONX, NY) - People taking oral ... have severe vitamin D deficiency, according to a study of ... Albert Einstein College of Medicine of Yeshiva University. ... Journal of Clinical Endocrinology and Metabolism, suggest that physicians should ...
... found that patients had little or no control over their ... care, but a new study shows that this has changed ... with health coverage that includes a high deductible and either ... their costs even after they initiated care. ...
... report appearing in the October 2011 issue of The ... resveratrol, the "healthy" ingredient in red wine, stops breast ... of estrogen. This discovery, made by a team of ... that resveratrol is able to counteract the malignant progression ...
... British Journal of Sports Medicine * highlights the injury risks ... of a school player suffering an injury during a single season ... could be as high as 90 per cent. The researchers ... University say there is an urgent need to inform children, parents ...
... dose of the hallucinogen psilocybin, the active ingredient in ... measureable personality change lasting at least a year in ... new study, according to the Johns Hopkins researchers who ... part of the personality known as openness, which includes ...
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Sept. 28 ... slightly above normal -- a condition known as prehypertension -- ... Normal blood pressure is a systolic blood pressure (top ... number) below 80 mmHg. Prehypertension is slightly above that ...
Cached Medicine News:Health News:Oral steroids linked to severe vitamin D deficiency in nationwide study 2Health News:Study finds consumers may have more control over health costs than previously thought 2Health News:Study finds consumers may have more control over health costs than previously thought 3Health News:Academic issues warning on schoolboy rugby 2Health News:Single dose of hallucinogen may create lasting personality change 2Health News:Single dose of hallucinogen may create lasting personality change 3Health News:Even Slightly Higher Blood Pressure May Boost Stroke Risk 2Health News:Even Slightly Higher Blood Pressure May Boost Stroke Risk 3
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
(Date:2/27/2015)... Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... fourth quarter and full year ended December 31, 2014. ... PTC. We are now a growing commercial-stage biopharma company, ... rare disease space," stated Stuart W. Peltz, Ph.D., Chief ... bring the first treatment for Duchenne muscular dystrophy to ...
(Date:2/27/2015)... , Feb. 27, 2015  Chiasma, Inc., a ... product for the orphan condition acromegaly, today announced the ... Participants in the financing included new investors Rock Springs ... public investment fund, as well as existing investors MPM ... ARCH Venture Partners. Chiasma intends to ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
... April 18, 2012 Financial executives in the medical ... and the burden of its related compliance costs will ... according to a survey conducted by KPMG LLP, the ... said their companies are already contemplating actions such as ...
... organiser UBM Live has revealed further details of ... CPhI Southeast Asia (SEA) 2012. Set to debut from 10-12 ... SEA is the first trade show and exhibition of its ... the ASEAN region. CPhI SEA will provide ...
Cached Medicine Technology:KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 2KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 3Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 2Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
Medicine Products: